Article | July 20, 2020

COVID-19 Changed Everything: Now Contracts And Budgets Need To Catch Up

Source: WCG

By Brooke Millman, JD, Vice President, Site Contracts & Budgets, Russell John, Global Director of Grants Management and Institution Benchmarking, and Tia Allison, Global Contracts Manager

Coronavirus COVID-19

As we emerge from crisis-response mode and embark on the path to recovery, we find ourselves—as a world, a country and an industry—in a period of transition and uncertainty.

While much remains unresolved, we do know this: Sites and sponsors will be recalibrating everything,  especially budgets for either new components of trials or changes to clinical trials. We anticipate that many site budgets will need to be recalculated, amended and renegotiated. We expect an increase in amendment requests across ongoing studies to modify site budgets beginning now and running through the fall.

At WCG Clintrax, we’ve outlined the 5 critical changes sites and sponsors should be considering to best plan for the future:

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: